Gregory M. Weinhoff, Chief Business Officer at Centessa Pharmaceuticals plc (CNTA), sold 22,988 shares at $15.25 ($351K) on 2025-02-25, disclosed to the SEC on 2025-02-26.
Scheduled sale ($351k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.25 | 11,494 | $175K | 50.0% |
| 2 | $15.25 | 11,494 | $175K | 50.0% |
| Total | $15.25 avg | 22,988 | $351K | 100% |
| Filing → |
| CNTA | SELL | 2025-07-25 | $156K | — | Filing → |
| CNTA | SELL | 2025-06-25 | $139K | — | Filing → |
| CNTA | SELL | 2025-05-27 | $128K | — | Filing → |